作为Nrf2信号通路的调节器的isoliquiritigenin:潜在的治疗影响
Mangmang Qiu1, Kang Ma2, Junfeng Zhang1
1School of Basic Medical Sciences, Xi'an Medical University, Xi'an, China.
Frontiers in pharmacology
|October 24, 2024
概括
异二基因因 (ISL) 激活Nrf2通路,为糖尿病和癌症等疾病提供抗氧化和治疗益处. 这篇评论探讨了ISL.
科学领域:
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 核因子2 (Nrf2) 是细胞保护细胞免受氧化应激的关键转录因子.
- Nrf2 调节抗氧化基因表达,减少活性氧物种 (ROS) 和保护细胞.
- Nrf2通路失调与各种疾病有关,使其成为治疗点.
研究的目的:
- 评估伊索利基基因因 (ISL) 在调节Nrf2信号通路方面的潜力.
- 通过Nrf2通路调制来总结ISL在疾病预防和治疗中的作用.
主要方法:
- 对研究ISL和Nrf2通路的文献综述.
- 分析ISL的药理学活动,重点关注抗氧化特性.
- 通过Nrf2激活在各种疾病模型中检查ISL的治疗效果.
主要成果:
- 伊索利基基因因 (ISL) 显示出显著的抗氧化特性.
- 通过ISL激活Nrf2信号通路.
- 在包括糖尿病,心血管疾病,脏疾病和癌症在内的疾病中,ISL具有治疗潜力.
结论:
- 伊索利基基因因 (ISL) 是调节Nrf2通路的一种有前途的化合物.
- ISL激活Nrf2有助于其在多种疾病条件中的治疗效果.
- 进一步研究ISL作为向Nrf2通路的治疗剂是有必要的.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Electron Transport Chain: Complex I and II
12.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


